Tuesday, 13 July 2021

We glad to inform you that our team has successfully developed Emtricitabine Impurities which are now In Stock at SynThink and available with CoA and all analytical data. 

Emtricitabine trans-Cyclic Impurity

CAT No.: SA22900
In Stock

Emtricitabine cis-Cyclic Impurity

CAT No.: SA22924
In Stock

Emtricitabine (S)-Sulphoxide Oxide

CAT No.: SA22925
In Stock

5-epi Emtricitabine

CAT No.: SA22901
In Stock

5-epi Emtricitabine Carboxylic Acid

CAT No.: SA22902
In Stock

(-)Emtricitabine S-Oxide (Mixture of Diastereomer

CAT No.: SA22923
In Stock

2-epi-Emtricitabine

CAT No.: SA22903
In Stock

Emtricitabine Menthyl Ester

CAT No.: SA22904
In Stock

Emtricitabine (R)-Sulphoxide Oxide

Catalog No. : SA22926
In Stock

ent-Emtricitabine

CAT No.: SA22906
In Stock

(2S,5R) Emtricitabine Carboxylic Acid

CAT No.: SA22913
In Stock

Emtricitabine N,N’-Methylene Dimer

CAT No.: SA22921
In Stock

(2R,5S) Emtricitabine Carboxylic Acid

CAT No.: SA22914
In Stock

(2S,5S) Emtricitabine Carboxylic Acid

CAT No.: SA22915
In Stock

(2R,5R) Emtricitabine Menthyl Ester

CAT No.: SA22918
In Stock

(2S,5R) Emtricitabine Menthyl Ester

CAT No.: SA22916
In Stock

(2S,5S) Emtricitabine Menthyl Ester

CAT No.: SA22917
In Stock

Emtricitabine

CAT No.: SA22905
In Stock

 

 

Emtricitabine Impurities: https://synthinkchemicals.com/product-category/impurities/emtricitabine-impurities/

 

Please feel free to come back to us in case you are interested in any of our products, or you want us to prepare any specific impurity (custom synthesis of unknown impurity) for your user. 

We assure you that you will fully be satisfied with the quality of our products. We are looking forward to a positive response.

 

 

 




Bhagyashri Adhav-Dhoke
Business development (API impurities)
Mob: - +91 8007179444
email: bd@synthinkchemicals.com
Website: www.synthinkchemicals.com

SynThink Research Chemicals
S. No. 80, Near JSPM Shahu College,
Mumbai Bypass, Tathawade, Pune,
Maharashtra, 411033.
India.


SynThink, A Trusted Source of Pharmaceutical Impurity Standards, Custom Synthesis

 

No comments:

Post a Comment